System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Katharine Barnard is an expert in Endocrinology at Southern Health NHS Foundation Trust (United Kingdom). As of October 2026, ScienceLeadR ranks Katharine Barnard in the top 1% of experts worldwide for Diabetes Mellitus and Glucose Metabolism Disorders. Katharine Barnard has authored 174 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 1 of them ongoing. SLR score: 700 (community average: 125). How the SLR is computed.

LeadR Profile

Katharine Barnard Southern Health NHS Foundation Trust United Kingdom
700 ScienceLeadR Reputation 700

Unlock

Register Login
Network Map

Endocrinology

Subspecialties: Cardiology - Public Health - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2026
Source: PubMed

Bournemouth University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 174

Citations

Citations: 6 274 1st author: 60 Last author: 30 Unique author: 4

Main journals

Diabet Med 29
J Diabetes Sci Technol 27
Diabetes Technol Ther 22
Pract Diabetes 9
Diabetes Care 8

Best Journals

N Engl J Med 3
Lancet 1
Lancet Diabetes Endocrinol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Driving-Related Glucose Monitoring Practices Among Insulin-Treated Adults With Type 2 Diabetes.
PMID 42218605 — diabetes mellitus, safety, insulin, hypoglycemic agents, hypoglycemia, diabetes mellitus, type 2		J Diabetes Sci Technol20260
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.
PMID 42092956 — glucagon-like peptide 1, metabolic diseases, kidney, therapeutics		Cardiovasc Diabetol20260
Psychosocial implications, acceptability and ethics of screening for paediatric type 1 diabetes: a systematic review and mixed methods evidence synthesis.
PMID 42065735 — diabetes mellitus, ethics, diabetes mellitus, type 1, child		Diabetologia20260
Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial.
PMID 42035781 — diabetes mellitus, self-management, blood glucose, insulin, blood, therapeutics, diabetes mellitus, type 2, continuous glucose monitoring		Lancet Diabetes Endocrinol Top journal20260
Exploring the psychosocial implications of general population screening for paediatric type 1 diabetes in Europe: Protocol for a mixed-methods study.
PMID 41933490 — diabetes mellitus, surveys and questionnaires, research, diabetes mellitus, type 1, child		Diabet Med20260

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 10
Phase 2 1

By status:

Completed 10
Active not recruiting 1

By type:

Interventional 10
Observational 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 3
multicentric5to9 1
multicentricup10 4

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
CGM Use in Adults With Type 2 Diabetes on Basal Insulin
NCT05944432 — diabetes mellitus, glucagon-like peptide 1, sodium-glucose transporter 2 inhibitors, blood glucose, insulin, blood, therapeutics, blood glucose self-monitoring, diabetes mellitus, type 2, continuous glucose monitoring		N/AActive not recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS